Peijia Medical Limited - Asset Resilience Ratio
Peijia Medical Limited (4WO) has an Asset Resilience Ratio of 1.70% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Peijia Medical Limited total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Peijia Medical Limited's Asset Resilience Ratio has changed over time. See Peijia Medical Limited (4WO) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Peijia Medical Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4WO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €45.78 Million | 1.7% |
| Total Liquid Assets | €45.78 Million | 1.70% |
Asset Resilience Insights
- Limited Liquidity: Peijia Medical Limited maintains only 1.70% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Peijia Medical Limited Industry Peers by Asset Resilience Ratio
Compare Peijia Medical Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 5.46% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.66% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
Annual Asset Resilience Ratio for Peijia Medical Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Peijia Medical Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.70% | €45.78 Million ≈ $53.53 Million |
€2.69 Billion ≈ $3.14 Billion |
-3.80pp |
| 2023-12-31 | 5.51% | €147.16 Million ≈ $172.04 Million |
€2.67 Billion ≈ $3.12 Billion |
+3.35pp |
| 2022-12-31 | 2.16% | €71.56 Million ≈ $83.67 Million |
€3.32 Billion ≈ $3.88 Billion |
+2.04pp |
| 2020-12-31 | 0.11% | €3.26 Million ≈ $3.81 Million |
€2.88 Billion ≈ $3.37 Billion |
-1.59pp |
| 2019-12-31 | 1.71% | €15.00 Million ≈ $17.54 Million |
€879.48 Million ≈ $1.03 Billion |
-- |
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company products inclu… Read more